Hummel, Heike: „Untersuchungen zum Postantibiotischen Effekt bei Pseudomonas aeruginosa-Isolaten einer Intensivstation“

60-64

Literaturverzeichnis

1 . Adam, D ". Antibiotika-Kombinationen: Ein ungelöstes Problem fürMikrobiologen und Kliniker" . Infektionen und Klinikhygiene 8 . 1989, 5 :35-36.

2 . Armstrong, G.C., Wise, R., Brown, R.M. and Hancox, J . "Comparison of Ceftazidime and Cefamandole Pharmacokinetics and Blister Fluid Concentrations" . Antimicrob Agents Chemother . 1981,9 : 356-358.

3 . Auwera, P . "Interactions between Antibiotics and Phagocytosis in Bacterial Killing" . Scand J Infect Dis . 1991, 74 :42-48.

4 . Baltch, A.L., Franke,M., Smith,R.P., Asperilla,M., Griffin, P., Michelsen and Lutz, F . "Serum Antibody Concentrations of Cytotoxin, Exotoxin A, Lipopolysaccharide, Protease and Elastase and Survival of Patients with Pseudomonas aeruginosa Bacteremia" . Clin Infect Dis . 1996, 23 :1109-1116.

5 . Betty, J., Mc Grath, M., Randall, C., Gilbert, D., Dudley, M.N . "In Vitro Postantibiotic Effect Following Repeated Exposure to Imipenem, Temafloxacin and Tobramycin" . Antimicrob Agents Chemother . 1993, 8 : 1723-1725.

6 . Blaser, J ., "Die Bedeutung des Quotienten von Spitzenkonzentration und MHK für die Wirkung von Antibiotika" . Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie . 1990, Band 9-2 :191-201.

7 . Blaser, J . "In-vitro und In-vivo-Untersuchungen von Antibiotika. Ursachen für Diskrepanzen" . Chemotherapie Journal . 1995, Suppl.5 :18-23.

8 . Blaser, J., König, C ., "Once Daily Dosing of Aminoglycosides" . Eur J Clin Microbiol Infect Dis . 1995, 14 :1029-1038.

9 . Boswell,F.J., Andrews,J.M., and Wise,R . "Pharmacodynamic Properties of BAY 12-8039 on Gram-Positive and Gram-Negative Organisms as Demonstrated by Studies of Time-Kill-Kinetics and Postantibiotics Effect" . Antimicrob Agents Chemother . 1997, 6 :1377-1379.

10 .Brandis, H., Köhler, W., Eggers, H.J., Pulverer, G . . 1994, 7.Auflage, Gustav Fischer Verlag, ISBN 3-437-00743-2

11 .Braveny, I., Machka, K., Milatovic, D . "Beurteilung neuer Pseudomonas-wirksamer Substanzen anhand des Serumbakterizidie-Tests" . Eur J Clin Microbiol . 1986, 5 :1-6.

12 .Brook, I . "Inoculum Effect" . Rev Infect Dis . 1989, 11 :361-368.

13 .Bundtzen, W. R., Gerber, A.U., Cohn, D.L., Craig, W.A . "Postantibiotic Suppression of Bacterial Growth" . Rev Infect Dis . 1981, 3 :28-37.

14 .Bustamante, C.I., Drusano,G.L., Tatem,B.A., Stam, H.C ., "Postantibiotic Effect of Imipenem on Pseudomonas aeruginosa" . Antimicrob Agents Chemother . 1984, 11 : 678-682.

15 .Cappelletty, D.M., Lena Kang, S., Palmer, S.M. and Rybak, M.J ". Pharmacodynamics of Ceftazidime Administered as Continuos Infusion or Intermittent Bolus Alone and in Combination with Single Daily-Dose Amikacin against Pseudomonas aeruginosa in an In Vitro Model" . Antimicrob Agents Chemother . 1995, 8 : 1797-1801.

16 .Ciofu, O., Giwercman, B., Pedersen, S.S. and Hoiby, N . "Development of antibiotics resistance in Pseudomonas aeruginosa during two Decades of antipseudomonal treatment at the Danish CF Center" . APMIS Suppl 102, 1994 , 674-680.

17 .Craig, W.A . "Interrelationship between Pharmacokinetics and Pharmacodynamics in Determining dosage regimes for Broad-Spectrum Cephalosporins" . Diagn Microbiol Infect Dis . 1995, 22 : 89-96.

18 .Craig, W.A., Ebert, S.C . "Killing and Regrowth of Bacteria in Vitro: A Review" . Scand J Infect Dis . 1991, 74 : 63-70.

19 .Dalhoff, A . "Aussagekraft pharmakokinetischer und pharmakodynamischer Parameter für die Wertbemessung von Chemotherapeutika" . Fortschritte der antimikrobiellen und antineoplastischen Chemotherapie . 1990, Band 9-2 : 175-189.

20 .Drusano, G.L . "Human Pharmacodynamics of Beta-lactams, Aminoglykosides and their Combination" . Scand J Infect Dis . 1991, 74 : 235-248.

21 .Dudley, M.N., Zinner, S.H . "Single daily dosing of amikacin in an in vitro model" . J Antimicrob Chemother . 1991, 27 : 15-19.

22 .Foca,A., Carbone, M., Mastroeni, P ". In vitro-Studie über die Synergistische Wirkung von Ceftriaxon in Kombination" . 5th Mediterranean Congress of Chemotherapy Kairo , 26.10.-1.11.1986.

23 .Fuursted, Kurt . "Postexposure Factors Influencing the Duration of Postantibiotic Effect: Significance of Temperature, pH, Cations, and Oxygen Tension" . Antimicrob Agents Chemother . 1997, 8 : 1693-1696.

24 .Gerber, A.U . "Postantibiotic effect: an update and an outlook on clinical relevance" . Infect Dis . 1993, 6 : 751-757.

25 .Gerber,A.U., Craig, W.A . "Experimentelle Studie zur Frage des optimalen Dosierungsintervalls in der Antibiotikatherapie" . Schweiz Med Wochenschr . 1982, 112 : 42-45.

26 .Gerber,A.U., Kozak, S., Segessenmann, C., Flückiger, U., Bangerter, T., Greter, U . "Once daily versus Thrice-Daily Administration of Netilmicin in Combination Therapy of Pseudomonas aeruginosa Infection in a Man-Adapted Neutropenic animal Model" . Eur J Clin Microbiol Infect Dis , 1989, 3 : 233-237.

27 .Giamarellou, H . "Aminoglycosides plus Beta-Lactams against Gram-Negative Organisms" . Am J Med , 1986, Vol 80 (Suppl 6B).

28 .Gilbert, D.N . "Once Daily Aminoglykoside Therapy- Minireview" . Antimicrob Agents Chemother , 1991, 35 : 399-405.

29 .Gillissen, G . "Immunmodulatorische Effekte von Antibiotika allein und in Verbindung mit Immunsuppressiva" . Z Ärztl Fortbild , 1992, 86 : 263-267.

30 .Gottfredsson, M., Erlendsdottir, A. and Gudmundsson, S . "Different Patterns of Bacterial DNA Synthesis during Postantibiotic Effect" . Antimicrob Agents Chemother , 1995, 39 : 1314-1319.

31 .Gottfredsson, M., Erlendsdottir, H., Siggfusson, A. and Gudmundsson, S . "Characteristics and Dynamics of Bacterial Populations durind Postantibiotic Effect Determined by Flow Cytometry" . Antimicrob Agents Chemother , 1998, 42 : 1005-1011.

32 .Grassias-Berardi, L.D., Boisvon, A., Chanviere, P., Guiomar, C . "In vitro- Aktivität der Kombination Ceftriaxon-Amikacin und Ceftriaxon-Piperacillin gegen Pseudomonas aeruginosa" . 5TH Mediterranean Congress of Chemotherapy 26.10.-1.11.1986 .

33 .Grimm, H . "In-vitro-Aktivität, Kreuzresistenz und Resistenztrends von Mezlocillin, Inhibitor geschützten Aminopenicillinen und Ampicillin" . Zeitschrift für antimikrobielle und antineoplastische Chemotherapie , 1994, 12 : 51-62.

34 .Gudmundsson, S., Erendsdottir, H., Gudmundsson, A . "The Postantibiotic Effect induced by Antimicrobial Combinations" . Scand J Infect Dis , 1991, 74 : 80-93.

35 .Gudmundsson, S., Vogelmann, B., Craig, W.A ". Decreased bactericidal activity during the period of the postantibiotic effect" . Antimicrob Chemother , 1994, 43 : 921-930.

36 .Gupta, C.B., Torre, M . "Chemical Stabilities of Cefperazone Sodium and Ceftazidime in 5% Dextrose and 0,9% Sodium Chloride Injections" . J Clin Pharm Ther , 1988, 13 : 199-205.

37 .Hanberger, H., Nilsson, L.E., Kihlström, E., Maller, R . "Postantibiotic effect of Beta-Lactam Antibiotics on Escherichia coli Evaluated by Bioluminescence Assay of Bacterial ATP" . Antimicrob Agents Chemothera , 1990, 34 : 102-106.

38 .Hanberger, H., Nilson, E., Maller, R., Nilsson, M . "Pharmacodynamics of Beta-Lactam Antibiotics on gram-negative Bacteria: Initial Killing, Morphology and Postantibiotic Effect" . Scand J Infect Dis , 1991, 74 : 118-123.

39 .Hallander, H.O., Dornbusch, K., Gezelius, L., Jacobson, K., Karlson, I . "Synergism between Aminoglycosides and Cephalosporins with Antipseudomonal Activity: Interaction Index and Killing Curve Method" . Antimicrob Agents Chemother , 1982, 22 : 743-752.

40 . Hilf, M., Yu, Vl., Sharp, J., Zuravleff, J., Korvick, J. and Muder, R . "Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients" . Am J Med , 1989 Nov, 87 : 540-546

41 .Hollander, J.G., Fuursted,K., Verbrugh,H.A., Mouton,J.W . "Duration and Clinical Relevance of Postantibiotic Effect in Relation to the Dosing Interval" . Antimicrob Agents Chemother , 1998,42 : 749-754.

42 .Hollander, J.G., Moutom, J.W., Goor, M-L.P.J., Vleggaar, F.P., Verbrugh, H.A . "Alteration of Postantibiotic effect during one dosing Interval of Tobramycin, Simulated in an in vitro Pharmakokinetic Model" . Antimicrob Agents Chemother , 1996, 40 : 784-786.

43 .Hollander, J.G., Mouton, J.W., Bakker-Woudenberg, I.A.J.M., Vleggaar, F.P., Goor, M.P.J., Verbrugh, H.A . "Enzymatic Method for Inactivation of Aminoglykosides during Measurement of Postantibiotic Effect" . Antimicrob Agents Chemother , 1996, 40 : 488-490.

44 .Hooton, T.M., Blair, A.D., Turck, M., Counts, G.W . "Concentrations of Aminoglykoside and Beta-Lactam Antibiotics" . Antimicrob Agents Chemother , 1984, 4 : 535-538.

45 .Hostacka, A . "Postantibiotic Effect and Virulence Factors Depression induced by Ciprofloxacin and by Aminoglykosides in a clinical Isolates of Pseudomonas aeruginosa" . Zentralbl Bak , 1996, 283 : 322-327.

46 .Issakson, B., Hanberger, H., Maller, R., Nilsson, L.E., Nilsson, M . "Synergic Postantibiotic effect of amikacin in Combination with Beta-Lactam antibioitics on gram-negative bacteria" . J Antimicrob Chemother , 1991, 28 : 25-34.

47 .Joly-Guillou, Marie-Laure, Wolf, M., Pocidalo, J.J., Walker, F., and Carbon, C . "Use of a New Mouse Model of Acinetobacter baumanii Pneumonia To Evaluate the Postantibiotic Effect of Imipenem" . Antimicrob Agents Chemother , 1997, 2 : 345-351.

48 .Kayser, F.H., Kohler, M.L . "Vergleich der antimikrobiellen Aktivitäten der Cephalosporine" . Schweiz Med Wochenschr , 1984, 114 : 151-161.

49 .Knothe,H . "Aminoglykoside- ihr Stellenwert heute" . Medizin im Dialog , 1996, 2 : 1-4.

50 .Kovarik, J.M., Hoepelmann, I.M., Verhoef, J . "Once- Daily Administration: New Strategies for an Old Drug" . Eur J Clin Microbiol Infect Dis .1989, 9 : 761-769.

51 .Laverdiere, M., Gallimore, B., Restier, C., Poonia, K., Chow, A.W . "In vitro Synergism of Ceftriaxone Combined with Aminoglykosides against Pseudomonas aeruginosa" . Diagn Microbiol Infect Dis , 1994, 19 : 39-46.

52 .Li, R.C., Lee, S.W., Lam, J.S . "Novel Method for Assessing Postantibiotic Effect by Using the Coulter Counter" . Antimicrob Agents Chemother , 1996, 6 : 1751-1753.

53 .Libby, J . "Postantibiotic Effect in Escherichia coli Determined with Real-Time Metabolic Monitoring" . Antimicrob Agents Chemother , 1998, 1 :78-82.

54 .Lode, H., Schaberg, T., Koeppe, P.,Borner, K . "Pharmakokinetik von Antibiotika und Infektlokalisation" . J Chemother ,1995, 5 : 15-17.

55 .Lorian, V., Ernst, J., Amaral, L . "The post-antibiotic effect defined by morphology" . J Antimicrob Chemother , 1989, 23 : 485-491.

56 .Mackenzie, F.M., Gould, I.M . "The Postantibiotic effect- Review" . J Antimicrob Chemother . 1993, 32 : 519-537.

57 .Manek,N., Andrews, J.M., Wise,R . "The post antibiotic effect of Imipenem" . J Antimicrob Chemother . 1986, 18 : 641-649.

58 .Masuda, N., Sakagawa, E., Ohya, S . "Outer membrane Proteins Responsible for Multiple Drug Resistance in Pseudomonas aeruginosa" . Antimicrob Agents Chemother , 1995, 39 : 645-649.

59 .Mc Donald, P.J., Wetherall, Prunl, H . "Postantibiotic Leukocyte Enhancement: Increased Susceptibility of Bacteria Pretreated with Antibiotics to Activity of Leukocytes" . Rev Infect Dis , 1981, 3 : 38-44.

60 .Mc Grath, B.J., Marchbanks, C.R., Gilbert, D., Dudley, M.N . "In vitro Postantibiotic Effect Following Repeated Exposure to Imipenem, Temafloxacin and Tobramycin" . Antimicrob Agents Chemother , 1993, 37 : 1723-1725.

61 .Meunier, F., Auwera, P., Aoun, M., Ibrahim, S., Tulkans, P.M . "Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytpopenie patients: a pilot study" . J Antimicrob Chemother , 1991, 27 : 129-139.

62 .Moore, R.D., Craig, R.S., Lietmann,P.S . "The Association of Aminoglycosides Plasma Levels with Mortality in Patients with gram-negative Bacteremia" . J Infect Dis , 1984, 149 : 443-448.

63 .Munckhof, W., Olden, D. and Turnidge, J . "The Postantibiotic Effect of Imipenem: Relationship with Drug Concentration, Duration of Exposure, and MIC" . Antimicrob Agents Chemother , 1997, 8 : 1735-1737.

64 .Naber, K.G., Wiedemann, B . "Bewertungskriterien für die antimikrobielle Chemotherapie" . Chemotherapie Journal , 1994, 2 : 47-52.

65 .Odenholt, I., Isaksson, B., Nilsson, L., Cars, O . "Postantibiotic and Bactericidal Effect of Imipenem against Pseudomonas aeruginosa" . J Clin Microb Infect Dis , 1989, 2 : 136-141.

66 .Odenholt-Tornquvist, I., Löwdin, E., Lars, O . "Pharmacodynamic Effects of Subinhibitory Concentrations of Beta-Lactam-Antibiotics in vitro" . Antimicrob Agents Chemother , 1991, 35 : 1834-1839.

67 .Piepersberg, W . "Aminoglycosid-Antibiotika: Wichtige Therapeutika und Objekte der Grundlagenforschung" . Forum Mikrobiologie , 1985, 8 : 153-161.

68 .Potel, G., Chau, N.P., Pangon, B., Fautin, B., Vallois, J.M., Faurisson, F., Carbon,C . "Single Daily Dosing of Antibiotics: Importance of in vitro Killing rate, Serum Half-Life, and Protein Binding" . Antimicrob Agents Chemother , 1991, 35 : 2085-2090.

69 .Raz,R., Adawie,M., Romano,S . "Intravenous Administration of Gentamicin Once Daily versus Thrice Daily in Adults" . Eur J Clin Microbiol Infect Dis . 1995, 14 :88-91

70 .Ronald, C.LI and SIU W. LEE . "Postantibiotic Effect Assessments for Antibiotics Ehibiting a Wide Range of Bactericidal Activities by Using a Modified Total-Cell-Counting Method" . Antimicrob Agents Chemother , 1997, 5 : 1170-1172.

71 .Ronald C.LI, ZHE Y. ZHU, SIU W. LEE, Kenneth Raymond, Julia M.L Ling, and Augustine F.B.Cheng . "Antibiotic Exposure and Its Relationship to Postantibiotic Effect and Bactericidal Activity: Constant versus Exponentially Decreasing Tobramycin Concentrations against Pseudomonas aeruginosa" . Antimicrob Agents Chemother , 1997, 8 : 1808-1811

72 .Sarubbi,F.A., Hull, J.H . "Amikacin Serum Concentrations: Prediction of Levels and Dosage Guidlines" . Ann Intern Med , 1978, 89 : 612-618.

73 .Schmid, E.N . "Feinstrukturelle Veränderungen der Bakterienzelle unter Fosfomycin-Einwirkung" . Berichtsband der Fosfomycin-Arbeitstagung , 1984 , 41-45.

74 .Sörgel, F., Kinzig, M . "Pharmakokinetik und Pharmakodynamik parenteraler Cephalosporine" . Chemotherapie Journal , 1995, 5 : 6-13.

75 .Spivey, J.M . "The Postantibiotic effect" . Clinical Pharmacy , 1992, 11: 865-875.

76 .Sturm,A.W . "Netilmicin-Therapie der gramnegativen Sepsis- Einmaldosierung wirksam und verträglich" . J Infect Dis . 1989, 159 : 931-937.

77 .Suller, M. and Lloyd,D . "Flow Cytometric Assessment of the Postantibiotic Effect of Methicillin on Staphylococcus aureus" . Antimicrob Agents Chemother , 1998, 5 : 1195-1199.

78 .Thorburn, C.E., Molesworth, S.J., Sutherland, R. and Rittenhouse, S . "Postantibiotic and Post-Beta-Lactamase Inhibitor Effects of Amoxicillin plus Clavulanate" . Antimicrob Agents Chemother , 1996, 40 : 2796-2801.

79 .Vogelmann, B., Craig, W.A . "Kinetics of antimicrobial activity" . J Pediatr , 1986, 108 : 835-840.

80 .Wallrauch-Schwarz, C., Milatovic, D., Braveny, I . "Bewertung des Bakterizidietestes" . Arzneimittel-Forschung , 1993, 43 : 1378-1381.

81 .Wiedemann, B . "Qualität eines Antibiotikums-Beurteilung mit in vitro Daten" . Chemotherapie Journal , 1995, 5 : 2-5.

82 .Wiedemann, B . "Resistenzmechanismen und ihre Ausbreitung" . Arzneimitteltherapie , 1992, Nr.12.

83 .Wiedemann,B. , Heisig; P . "Beurteilung der Resistenzentwicklung als Faktor für die Einschränkung therapeutischer Möglichkeiten" . Infection , 1991, 1 :47-50.

84 .Zielmann, S . "Methode zur individuellen Anpasung der einmal täglichen Dosierung von Aminoglykosidantibiotika" . Chemotherapie Journal , 1995, 2 : 61-62.

85 .Zielmann, S., Lotterer, E . "Grundlagen und Durchführung einer individuellen Therapie mit Aminoglykosidantibiotika" . Intensivmedizin , 1991, 28 : 124-132.

86 .Xiong, Y.Q., Caillon, J., Drugeon, H. Potel, G., Baron,D . "Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglykosides and their Postantibiotic Effect" . Antimicrob Agents Chemother , 1996, 40 : 35-39.

87 . DIN Taschenbuch Medizinische Mikrobiologie und Immunologie , Beuth Verlag 1992, 2.Auflage, ISBN 3-410-12689-9


[Titelseite] [1] [2] [3] [4] [5] [Bibliographie] [Danksagung] [Selbständigkeitserklärung] [Lebenslauf]

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.

DiML DTD Version 2.0
Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML - Version erstellt am:
Thu Sep 14 10:58:29 2000